Thomas Oppelt
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 11, 2026
Management of patients hospitalized for SARS-CoV-2 infection: A real-world economic evaluation from the hospital perspective.Andre C Kalil, Mohsen Yaghoubi, Neera Ahuja
|Feb 09, 2026
Lower mortality risk associated with remdesivir plus corticosteroids vs corticosteroids alone for the treatment of patients hospitalized with SARS-CoV-2 infection in the early and later Omicron periods.Alpesh N Amin, Thomas Oppelt, Aastha Chandak
|May 05, 2025
Economic Evaluation of Population-Level Chronic Kidney Disease Interventions in the UK National Health Service.George Agathangelou, Matthew Graham-Brown, Aisling C McMahon
|Oct 15, 2024
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
|Sep 20, 2024
Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
|Feb 29, 2024
Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study.Essy Mozaffari, Aastha Chandak, Robert L Gottlieb
Pageof 2
Frequent Collaborators
4 joint publications
Aastha Chandak
3 joint publications
Robert L Gottlieb
3 joint publications
Chidinma Chima-Melton
3 joint publications
Andre C Kalil
3 joint publications
Mark Berry
3 joint publications
Alpesh N Amin
2 joint publications
Jacob Jaffe
1 joint publications
Matthew Graham-Brown
1 joint publications
Heng Jiang
